Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement (Replacement)

19 Jun 2017 08:18

RNS Number : 4387I
InnovaDerma PLC
19 June 2017
 

The following replaces The Trading Statement Announcement released at 07.00 hours today under RNS number 4017I and amends the Full Year date to 30 June 2017.All other details in the announcement remain the same. The full text of the amended announcement is set out below.

 

InnovaDerma PLC

 ("InnovaDerma" or the "Company")

Pre-close Trading Update

Trading Performance - Well Ahead of Expectations

InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, is pleased to announce that it expects revenue and profits for the full year to 30 June 2017 will be well ahead of expectations. Overall revenues are expected to increase by 80% on a constant currency basis to approximately £9 million. Revenues have been bolstered by the exceptional performance of Skinny Tan through the Company's fast-expanding Direct to Consumer platform and retail channels, with the brand achieving the highest-monthly revenues for four months in the second half of financial year 2017. Underlying profit before tax is expected to increase by 355% to approximately £1.28 million excluding one-off costs (2016: £0.281 million on a constant currency basis) driven by a more efficient supply chain which has led to an improvement in gross margin of approximately 62% (2016: 57.4%), up 400 bps.

The Group has maintained a strong balance sheet.

 

New Operational Developments

 

InnovaDerma is pleased to announce the following new operational developments:

· As previously announced on 1 June 2017, Boots Ireland had agreed to stock Skinny Tan in at least 35 of their largest stores. Boots Ireland has agreed to increase this to 65 stores out of their 80 stores and the Skinny Tan range will be available on their shelves from July 2017.

· The Company has secured a new and important channel to enhance Skinny Tan Professional sales in the UK through a partnership with the London School of Beauty & Make-up. Part of the Urban Retreat group of companies, the school is one of the UK's largest private education providers in the beauty sector and trains more than 1,000 beauty specialists per year, working alongside brands such as Mac, Laura Mercier and Murad. This strategic channel is expected to cement the Company's long-term future in the highly lucrative professional spray tanning sector.

· The Company has developed and launched a skin brightening and anti-ageing product portfolio in Korea which has received KFDA (Korean Food & Drug Administration) approval. The product brightens skin, contains SPF 50 and reduces the signs of ageing. The range has initially been launched in 600 pharmacies and beauty stores by the Company's distributor, PROS International Company Ltd of Korea. Skin Lightening / Brightening market is a fast growing skin care segment and is expected to reach over US $20 billion per annum by 2020.*

http://www.strategyr.com/MarketResearch/Skin_Lighteners_Market_Trends.asp

 

The Board is pleased with the progress being made and looks forward to discussing this further at the time of its final results.

Haris Chaudhry, Executive Chairman of InnovaDerma said:

"We have been working hard to execute our strategy and I am delighted that this has delivered strong sales and growth in profitability. Our ability to extend our flagship brand, Skinny Tan, to launch new products successfully and to expand our diverse portfolio of premium brands, together with a robust balance sheet, means we are strongly positioned for future growth."

Further enquiries:

InnovaDerma

Haris Chaudhry/Joe Bayer

 

+61 (0)3 9111 0071

Sole broker

Hybridan LLP

Claire Noyce

 

+44 (0)203 764 2341

Cardew Group

Shan Shan Willenbrock

David Roach

 

+ 44 (0)20 7930 0777

 

About InnovaDerma:

InnovaDerma PLC (LSE: IDP) specializes in the research, manufacture and marketing of clinically proven products in life sciences, beauty and personal care products. InnovaDerma has presence in the UK, US, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.

 

www.innovaderma.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGRGDLDBBBGRC
Date   Source Headline
15th Feb 202112:22 pmBUSForm 8.3 - INNOVADERMA PLC
12th Feb 20216:25 pmRNSForm 8.3 - Innovaderma PLC
12th Feb 20214:43 pmRNSForm 8.3 - [InnovaDerma plc]
12th Feb 20214:40 pmRNSForm 8.3 - [InnovaDerma plc]
12th Feb 20212:35 pmRNSForm 8.3 - Creightons
11th Feb 202111:50 amRNSForm 8.3 - Innovaderma plc
10th Feb 202111:25 amRNSForm 8.3 - Innovaderma plc
10th Feb 202111:03 amRNSForm 8.3 - Innovaderma PLC
9th Feb 20211:18 pmBUSForm 8.3 - INNOVADERMA PLC
5th Feb 20215:14 pmRNSForm 8.3 - Innovaderma Plc
4th Feb 20215:37 pmRNSForm 8 (OPD) CREIGHTONS
4th Feb 20213:31 pmRNSForm 8 (OPD) InnovaDerma PLC
3rd Feb 202112:27 pmBUSForm 8.3 - Innovaderma Plc
2nd Feb 20214:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20214:35 pmRNSPrice Monitoring Extension
2nd Feb 20214:12 pmGNWForm 8.3 - [InnovaDerma plc]
2nd Feb 20212:05 pmRNSSecond Price Monitoring Extn
2nd Feb 20212:00 pmRNSPrice Monitoring Extension
2nd Feb 202111:41 amRNSStatement re Possible Offer
2nd Feb 202111:05 amRNSSecond Price Monitoring Extn
2nd Feb 202111:00 amRNSPrice Monitoring Extension
2nd Feb 20219:05 amRNSSecond Price Monitoring Extn
2nd Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 202111:22 amRNSHolding(s) in Company
22nd Jan 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
20th Jan 20219:19 amRNSProposed Placing and Proposed Open Offer
18th Jan 202111:59 amRNSHolding(s) in Company
15th Jan 20214:41 pmRNSSecond Price Monitoring Extn
15th Jan 20214:35 pmRNSPrice Monitoring Extension
15th Jan 20217:00 amRNSLoan Agreement
11th Jan 20217:08 amRNSTrading Statement
16th Dec 202012:18 pmRNSResults of the AGM and GM and Directorate Change
2nd Dec 20207:00 amRNSDirectorate Change
24th Nov 20207:02 amRNSDirectorate Change
24th Nov 20207:00 amRNSNotice of General Meeting and adjournment of AGM
18th Nov 20207:00 amRNSDirectorate Change
11th Nov 202012:07 pmRNSAdjournment of AGM
29th Oct 20208:45 amRNSHolding(s) in Company
29th Oct 20208:28 amRNSDirector/PDMR Shareholding
27th Oct 20204:41 pmRNSSecond Price Monitoring Extn
27th Oct 20204:36 pmRNSPrice Monitoring Extension
27th Oct 20202:05 pmRNSSecond Price Monitoring Extn
27th Oct 20202:01 pmRNSPrice Monitoring Extension
23rd Oct 20202:05 pmRNSRequisition notice and Progress of CEO appointment
16th Oct 20204:32 pmRNSNotice of AGM
16th Oct 20209:21 amRNSAppointment of Non-executive Director
15th Oct 20204:40 pmRNSSecond Price Monitoring Extn
15th Oct 20204:35 pmRNSPrice Monitoring Extension
15th Oct 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.